FDA

2 Articles
Dr Moira Gilchrist PMI Vice President Strategic and Scientific Communications
SMART BUSINESS

Modified Risk Tobacco Products and the Future of Smoking

There is need for public and private collaborative strategies to substantially contribute to less harm in society

Philip Morris on Tobacco Regulation
OPINION

Tobacco Regulation Should Offer Consumers a Better Option

In a historic decision on July 7, the US Food and Drug Administration authorized the marketing of IQOS as a Modified Risk Tobacco...